By Reuters April 25, 201812:19 PM UTCUpdated ago April 25 (Reuters) - Cadila Healthcare Ltd: * SAYS ZYDUS GETS FINAL APPROVAL FROM USFDA FOR METHYLPREDNISOLONE TABLETS USP AND CINACALCET ...

Methylprednisolone and prednisone are both corticosteroids. Corticosteroids can reduce inflammation in the body and relieve related symptoms, such as body pain, swelling, and stiffness.

An unadjusted analysis of the primary end point showed an odds ratio for a worse outcome of 0.82 (95% CI, 0.67 to 1.00) and a win ratio of 1.15 (95% CI, 1.00 to 1.32) in the methylprednisolone ...